Shi‐Ping Yang - Concepedia

Author

Shi‐Ping Yang

Hainan General Hospital ORCID

Also Known As

S Yang, S. ‐C. Yang, S.-C. Yang, SHIPING YANG, Shi-Ping Yang, Shi-ping Yang, Shiping Yang, Shi‐Ping Yang

Publications

333

Citations

H-Index

Concepts

All Affiliations

Hainan General Hospital Haikou City People's Hospital First Affiliated Hospital of Xiamen University Nanfang Hospital Hainan Medical University

About

Shi‐Ping Yang is an author at Hainan General Hospital specializing in radiation oncology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	27
2	Cell Biology	1	1	17
3	Pathology	1	1	10
4	Cancer Genetics	1	1	17
5	Cancer Therapeutics	1	1	10

Shi‐Ping Yang

Publications

225

Citations

H-Index

Page 1

	Year	Citations
Cyanidin-3-o-glucoside directly binds to ERα36 and inhibits EGFR-positive triple-negative breast cancer Li Wang, Haifeng Li, Shi‐Ping Yang, Oncotarget	2016	38
Long-Term Survival Among Histological Subtypes in Advanced Epithelial Ovarian Cancer: Population-Based Study Using the Surveillance, Epidemiology, and End Results Database Shi‐Ping Yang, Huiluan Su, Xiu-Bei Chen, JMIR Public Health and Surveillance	2021	25
lnc‑MICAL2‑1 sponges miR‑25 to regulate DKK3 expression and inhibits activation of the Wnt/β‑catenin signaling pathway in breast cancer Jia Yao, Guanqiao Li, Minfeng Liu, International Journal of Molecular Medicine	2021	25
Invasive micropapillary carcinoma of the breast had poor clinical characteristics but showed no difference in prognosis compared with invasive ductal carcinoma Guanqiao Li, Shi‐Ping Yang, Jia Yao, World Journal of Surgical Oncology	2016	24
Change in phenolic compound content, reductive capacity and ACE inhibitory activity in noni juice during traditional fermentation Shi‐Ping Yang, Tai-Liang Chen, K.-Y. Li, Journal of Food and Drug Analysis	2020	20
An outbreak of enterically transmitted non‐A, non‐E viral hepatitis Kun Luo, L. Zhang, S. ‐S. Wang, Journal of Viral Hepatitis	1999	19
CircNCOR1 regulates breast cancer radiotherapy efficacy by regulating CDK2 via hsa-miR-638 binding Zhen-Yu He, Rengong Zhuo, Shi‐Ping Yang, Cellular Signalling MedicineHsa-mir-638 BindingBreast CancerCancer BiologyCell Biology	2023	17
An open-label, single-arm phase II clinical study of induction chemotherapy and sequential Nimotuzumab combined with concurrent chemoradiotherapy in N3M0 stage nasopharyngeal carcinoma. Shuai Zhang, Xiaopeng Huang, Liya Zhou, PubMed	2019	14
Additional radiotherapy to breast‐conserving surgery is an optional treatment for de novo stage IV breast cancer: A population‐based analysis Jun Wang, Shi‐Ping Yang, Ping Zhou, Cancer Medicine	2021	12
The Effect of Adjuvant Chemotherapy on Survival in Patients with Residual Nasopharyngeal Carcinoma after Undergoing Concurrent Chemoradiotherapy Shi‐Ping Yang, Shaomin Lin, Qiang Fu, PLoS ONE	2015	11

Page 1